A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 in Patients With Advanced Solid Tumors
Clinical trial NCT05911984 · UNKNOWN
Trial details
- NCT number
- NCT05911984
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-30
- Primary completion
- 2024-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.